291 related articles for article (PubMed ID: 27419383)
1. Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States.
Palamar JJ; Barratt MJ; Ferris JA; Winstock AR
Am J Addict; 2016 Aug; 25(5):400-7. PubMed ID: 27419383
[TBL] [Abstract][Full Text] [Related]
2. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
Palamar JJ; Martins SS; Su MK; Ompad DC
Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
[TBL] [Abstract][Full Text] [Related]
3. Self-reported use of novel psychoactive substances among attendees of electronic dance music venues.
Palamar JJ; Acosta P; Sherman S; Ompad DC; Cleland CM
Am J Drug Alcohol Abuse; 2016 Nov; 42(6):624-632. PubMed ID: 27315522
[TBL] [Abstract][Full Text] [Related]
4. Motivations for new psychoactive substance use among regular psychostimulant users in Australia.
Sutherland R; Bruno R; Peacock A; Lenton S; Matthews A; Salom C; Dietze P; Butler K; Burns L; Barratt MJ
Int J Drug Policy; 2017 May; 43():23-32. PubMed ID: 28161577
[TBL] [Abstract][Full Text] [Related]
5. Assessing self-reported use of new psychoactive substances: The impact of gate questions.
Palamar JJ; Acosta P; Calderón FF; Sherman S; Cleland CM
Am J Drug Alcohol Abuse; 2017 Sep; 43(5):609-617. PubMed ID: 28485987
[TBL] [Abstract][Full Text] [Related]
6. I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.
Matthews A; Sutherland R; Peacock A; Van Buskirk J; Whittaker E; Burns L; Bruno R
Int J Drug Policy; 2017 Feb; 40():44-49. PubMed ID: 27939599
[TBL] [Abstract][Full Text] [Related]
7. Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.
Schifano F; Papanti GD; Orsolini L; Corkery JM
Expert Rev Clin Pharmacol; 2016 Jul; 9(7):943-54. PubMed ID: 26985969
[TBL] [Abstract][Full Text] [Related]
8. Novel psychoactive substance and other drug use by young adults in Western australia.
Goggin LS; Gately N; Bridle RI
J Psychoactive Drugs; 2015; 47(2):140-8. PubMed ID: 25950594
[TBL] [Abstract][Full Text] [Related]
9. New psychoactive substance use among regular psychostimulant users in Australia, 2010-2015.
Sutherland R; Peacock A; Whittaker E; Roxburgh A; Lenton S; Matthews A; Butler K; Nelson M; Burns L; Bruno R
Drug Alcohol Depend; 2016 Apr; 161():110-8. PubMed ID: 26880592
[TBL] [Abstract][Full Text] [Related]
10. Attitudes and Beliefs About New Psychoactive Substance Use Among Electronic Dance Music Party Attendees.
Palamar JJ; Acosta P; Cleland CM
Subst Use Misuse; 2018 Feb; 53(3):381-390. PubMed ID: 28777688
[TBL] [Abstract][Full Text] [Related]
11. Self-Reported Ecstasy/MDMA/"Molly" Use in a Sample of Nightclub and Dance Festival Attendees in New York City.
Palamar JJ; Acosta P; Ompad DC; Cleland CM
Subst Use Misuse; 2017 Jan; 52(1):82-91. PubMed ID: 27661470
[TBL] [Abstract][Full Text] [Related]
12. Detection of "bath salts" and other novel psychoactive substances in hair samples of ecstasy/MDMA/"Molly" users.
Palamar JJ; Salomone A; Vincenti M; Cleland CM
Drug Alcohol Depend; 2016 Apr; 161():200-5. PubMed ID: 26883685
[TBL] [Abstract][Full Text] [Related]
13. Polysubstance use profiles among electronic dance music party attendees in New York City and their relation to use of new psychoactive substances.
Fernández-Calderón F; Cleland CM; Palamar JJ
Addict Behav; 2018 Mar; 78():85-93. PubMed ID: 29128711
[TBL] [Abstract][Full Text] [Related]
14. The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations.
Soussan C; Kjellgren A
Int J Drug Policy; 2016 Jun; 32():77-84. PubMed ID: 27184218
[TBL] [Abstract][Full Text] [Related]
15. Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene.
Palamar JJ; Salomone A; Gerace E; Di Corcia D; Vincenti M; Cleland CM
Int J Drug Policy; 2017 Oct; 48():91-98. PubMed ID: 28810159
[TBL] [Abstract][Full Text] [Related]
16. Use of synthetic stimulants and hallucinogens in a cohort of electronic dance music festival attendees.
Mohr ALA; Friscia M; Yeakel JK; Logan BK
Forensic Sci Int; 2018 Jan; 282():168-178. PubMed ID: 29216523
[TBL] [Abstract][Full Text] [Related]
17. Next generation of novel psychoactive substances on the horizon - A complex problem to face.
Zawilska JB; Andrzejczak D
Drug Alcohol Depend; 2015 Dec; 157():1-17. PubMed ID: 26482089
[TBL] [Abstract][Full Text] [Related]
18. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
Liechti M
Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018
[TBL] [Abstract][Full Text] [Related]
19. Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007-2014.
Neicun J; Yang JC; Shih H; Nadella P; van Kessel R; Negri A; Czabanowska K; Brayne C; Roman-Urrestarazu A
PLoS One; 2020; 15(10):e0241056. PubMed ID: 33125395
[TBL] [Abstract][Full Text] [Related]
20. Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?
Hondebrink L; Zwartsen A; Westerink RHS
Pharmacol Ther; 2018 Feb; 182():193-224. PubMed ID: 29097307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
